↓ Skip to main content

Dove Medical Press

Brexpiprazole for the maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy

Overview of attention for article published in Neuropsychiatric Disease and Treatment, January 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

blogs
1 blog
twitter
2 X users
facebook
2 Facebook pages
f1000
1 research highlight platform

Readers on

mendeley
60 Mendeley
Title
Brexpiprazole for the maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy
Published in
Neuropsychiatric Disease and Treatment, January 2019
DOI 10.2147/ndt.s169369
Pubmed ID
Authors

Kristen Ward, Leslie Citrome

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 60 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 9 15%
Student > Master 8 13%
Other 7 12%
Professor > Associate Professor 6 10%
Student > Doctoral Student 4 7%
Other 15 25%
Unknown 11 18%
Readers by discipline Count As %
Medicine and Dentistry 21 35%
Pharmacology, Toxicology and Pharmaceutical Science 8 13%
Nursing and Health Professions 4 7%
Psychology 3 5%
Unspecified 2 3%
Other 9 15%
Unknown 13 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 September 2021.
All research outputs
#3,750,998
of 25,584,565 outputs
Outputs from Neuropsychiatric Disease and Treatment
#554
of 3,120 outputs
Outputs of similar age
#82,255
of 448,033 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#9
of 75 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,120 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,033 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 75 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.